Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Genetic Testing × Genitourinary × Clear all

Status

Completed 4 Recruiting 3 Unknown 1 Terminated 1 Suspended 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

Docetaxel 58 pembrolizumab 35 Prednisone 33 Nivolumab 33 enzalutamide 29 Gemcitabine 29 Sunitinib 27 Cyclophosphamide 26 Leuprolide 22 Everolimus 21 Sorafenib 20 Magnetic Resonance Spectroscopy 20 Radiotherapy 19 bicalutamide 17 Cisplatin 17 Abiraterone Acetate 17 avelumab 15 Interleukin-2 15 Radiosurgery 14 Goserelin 14 Carboplatin 14 fludarabine 13 atezolizumab 13 Radiotherapy, Intensity-Modulated 13 Bevacizumab 13 abiraterone 12 Doxorubicin 12 durvalumab 11 cabazitaxel 11 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡